D
David Spiegel
Researcher at Stanford University
Publications - 838
Citations - 50967
David Spiegel is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 106, co-authored 733 publications receiving 46276 citations. Previous affiliations of David Spiegel include Tel Aviv University & University of Adelaide.
Papers
More filters
Journal ArticleDOI
Psychosocial predictors of resilience after the September 11, 2001 terrorist attacks.
Lisa D. Butler,Cheryl Koopman,Jay Azarow,Christine Blasey,Juliette C. Magdalene,Sue Dimiceli,David A. Seagraves,T. Andrew Hastings,Xin-Hua Chen,Robert W. Garlan,Helena C. Kraemer,David Spiegel +11 more
TL;DR: Findings highlight the role of emotional, coping, social support, and particularly, cognitive variables in adjustment after terrorism in those indirectly exposed to 9/11.
Journal ArticleDOI
Relaxation training and memory improvement in elderly normals: Correlation of anxiety ratings and recall improvement
TL;DR: Elderly subjects rated for degree of anxiety were taught a progressive muscle relaxation technique and improved on a list learning measure when they were relaxed, whereas subjects with relatively low levels of anxiety showed impairment of learning after relaxation.
Journal ArticleDOI
Suppression, repressive-defensiveness, restraint, and distress in metastatic breast cancer: separable or inseparable constructs?
Janine Giese-Davis,David Spiegel +1 more
TL;DR: The results support the discriminant validity of repressive-defensiveness, suppression, restraint, and distress constructs in the total sample of metastatic breast cancer patients, and the stability over 1 year in the control group.
Journal ArticleDOI
A Chemically Induced Vaccine Strategy for Prostate Cancer
Anna Dubrovska,Chan Hyuk Kim,Jimmy Elliott,Weijun Shen,Tun-Hsun Kuo,Dong-In Koo,Chun Li,Tove Tuntland,Jonathan Chang,Todd Groessl,Xu Wu,Vanessa Gorney,Teresa Ramirez-Montagut,David Spiegel,Charles Y. Cho,Peter G. Schultz +15 more
TL;DR: The ability to create a small molecule inducible antibody response against self-antigens using endogenous non-autoreactive antibodies may provide advantages over the autologous immune response generated by conventional vaccines in certain therapeutic settings.